Upcoming IPO: Jainik Power and Cables IPO opens on June 10; issue price band set at ₹100-110 apiece; check GMP

Upcoming IPO: Jainik Power and Cables Ltd IPO will open for subscription on Tuesday, June 10 and close on Thursday, June 12. Jainik Power and Cables IPO price band has been fixed in the range of ₹ 100 to ₹ 110 per equity share of face value of ₹ 10 each. Bids can be made for a minimum of 1,200 equity shares and in multiples of 1,200 equity shares thereafter.
Jainik Power and Cables Limited has been producing aluminum wire rods since 2023 and boasts over ten years of experience in the metal sector, having previously engaged in the trading of aluminum rods.
The firm manufactures and distributes aluminum wire rods while complying with Environmental, Health, and Safety (EHS) regulations, as evidenced by its ISO certifications. Its Quality Assurance Department performs purity assessments utilising spectrometers to identify concealed impurities.
The company markets its products across the regions of Delhi, Haryana, Rajasthan, Uttar Pradesh, and Uttarakhand.
As per the red herring prospectus (RHP), the company's listed peers are Hind Aluminium Industries Ltd (with a P/E of 13.73), and Arfin India Ltd (with a P/E of 43.23).
Jainik Power and Cables IPO consists of a fresh issue of 46,63,200 equity shares, aggregating to ₹ 51.30 crore. There's no offer for sale (OFS) component.
The Jainik Power and Cables IPO aims to use the net proceeds from the offering for several purposes, including meeting working capital needs, funding and establishing a plant, repaying part of the loans taken by the company, covering general corporate expenses, and addressing issue-related costs.
Fast Track Finsec Pvt Ltd is the primary lead manager for the Jainik Power and Cables IPO, whereas Skyline Financial Services Private Ltd acts as the registrar for the offering. The market maker for the Jainik Power and Cables IPO is Rikhav Securities Limited.
Jainik Power and Cables IPO GMP today or grey market premium was ₹ 0, which meant shares were trading at their issue price of ₹ 110 with no premium or discount in the grey market according to investorgain.com
'Grey market premium' indicates investors' readiness to pay more than the issue price.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

2 days ago

• Business Standard

Accenture sees strong Q3 with $17.7 billion revenue, ups FY25 guidance

Accenture delivered a robust performance in the third quarter of fiscal year 2025, with revenue rising 8 per cent year-on-year to $17.7 billion—surpassing Wall Street expectations of $17.3 billion. Earnings per share (EPS) increased 15 per cent to $3.49, while operating margin improved to 16.8 per cent, reflecting strong execution across the business. Buoyed by the solid Q3 results, Accenture raised its full-year local currency revenue growth forecast to a range of 6–7 per cent, up from its earlier guidance of 5–7 per cent. Free cash flow guidance was also revised upward and is now expected to fall between $9 billion and $9.7 billion. Full-year EPS is projected in the range of $12.77 to $12.89. Gen AI drives momentum despite bookings decline New bookings for the quarter totalled $19.7 billion, marking a 6 per cent decline in US dollar terms. Consulting contributed $9.08 billion, while managed services accounted for $10.62 billion. Notably, generative AI-related bookings reached $1.5 billion, indicating growing enterprise demand in emerging technologies. Despite the overall dip in bookings, Accenture recorded 30 clients with quarterly bookings exceeding $100 million, reflecting the strength of its client relationships. 'I am very pleased with our third quarter fiscal 2025 results, including our 30 clients with quarterly bookings greater than $100 million, broad-based growth and continued expansion of our leadership in Gen AI,' said Chair and CEO Julie Sweet. 'Companies need resilience and results, and we are laser-focused on delivering measurable value for our clients,' she added. Growth spans services, industries and geographies Managed services revenue climbed 9 per cent year-on-year to $8.72 billion, while consulting revenue rose 7 per cent to $9.01 billion. Regionally, the Americas led with $8.97 billion in revenue, followed by EMEA at $6.23 billion and Asia Pacific at $2.53 billion. From an industry standpoint, the Products segment remained a significant contributor with $5.34 billion in revenue. Financial Services led growth with a 13 per cent increase in local currency, while Health & Public Service posted 7 per cent growth. Accenture generated $3.5 billion in free cash flow during the quarter and declared a quarterly dividend of $1.48 per share. (With agency inputs)

Business Standard

3 days ago

• Business Standard

Monolithisch India lists at 62% premium on NSE SME, beats GMP estimates

Monolithisch India IPO listing today: Shares of Monolithisch India made a solid market debut on Thursday, June 19, listing at ₹231.55 on the NSE SME, a premium of 61.9 per cent from its issue price of ₹143. Post-listing the stock was trading at ₹243.1, up 5 per cent from the listing price. Monolithisch India listing was above the grey market estimates. Ahead of listing, the unlisted shares of Monolithisch India were trading at ₹182, commanding a premium of ₹39 or 27 per cent compared to the issue price. Monolithisch India IPO subscription The company offered shares in the price band of ₹135 to ₹143 with a lot size of 1,000 shares. It received bids for 69,80,10,000 shares against the 38,15,000 shares offered, resulting in an oversubscription of 182 times by the end of the subscription period, showed NSE data. Monolithisch India IPO details Monolithisch India IPO was a fresh issue of 5.44 million equity shares to raise ₹82.02 crore. There was no offer for sale (OFS) component. Monolithisch India IPO was available for subscription from Thursday, June 12, 2025, till Monday, June 16, 2025. The basis of allotment of shares was finalised on Tuesday, June 17, 2025. Kfin Technologies was the registrar of the issue. Hem Securities was the book-running lead manager of the Monolithisch India IPO. According to the red herring prospectus (RHP), Monolithisch India proposes to utilise the proceeds from the IPO for setting up a manufacturing facility and investment in its subsidiary, Metalurgica India. In addition, the company will use the proceeds to meet working capital requirements and general corporate purposes. About Monolithisch India Incorporated in August 2018, Monolithisch India manufactures and supplies "ramming mass," a head insulation refractory used in the iron and steel industry induction furnaces. The company produces various grades of ramming mass with different specifications and additives. The company is an ISO-certified entity with a manufacturing facility in Purulia, West Bengal. The company's products are used by iron and steel producers primarily in Eastern India, including West Bengal, Jharkhand, and Odisha.

Economic Times

3 days ago

• Economic Times

Jhunjhunwala family-backed IKS Health sees Rs 500 crore block deal; stock slides 4%

Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Around 30 lakh shares of IKS Health , the tech-driven healthcare services firm backed by the Jhunjhunwala family , changed hands in a block deal worth Rs 499 crore on Thursday, representing 1.75% of the company's equity. The stock slipped as much as 3.7% intraday to Rs 1,640.55 on the BSE following the shares were traded at an average price of Rs 1,659, with the floor price set at Rs 1,650—a 2.6% discount to Wednesday's closing price of Rs 1,695, CNBC-TV18 reported. The identities of the buyers and sellers were not officially disclosed, though sources told CNBC-TV18 that multiple individual investors were likely on the sell block deal came just a day after the end of IKS Health's six-month post-IPO lock-in period on Wednesday. With the lock-in lifted, 10.5 crore shares—worth nearly $20 billion—became eligible for trade. Market participants had been anticipating such a stock has now fallen over 12% in two sessions and is trading about 22% below its post-listing high of Rs 2, Health is backed by the Jhunjhunwala family through three discretionary trusts—Nistha, Aryavir, and Aryaman—each holding a 16.37% stake in the company as of March 2025. Rekha Jhunjhunwala also holds a 0.23% stake but did not participate in the IPO the company listed on December 19, 2024, the Jhunjhunwala family reportedly made a staggering 530x return on their investment. The Rs 2,500 crore IPO was oversubscribed 53 times and debuted at Rs 1,900 on the NSE, a 43% premium over the issue price of Rs 1, part of the offer-for-sale, the three family trusts offloaded 33.57 lakh shares out of the 8.94 crore they held as of the September quarter. The IPO did not involve any fresh capital Health, formally known as Inventurus Knowledge Solutions, provides a care enablement platform for physician enterprises across the US, Canada, and Australia, with a primary focus on the US market. It serves more than 778 healthcare organizations, including high-profile clients such as Mass General Brigham Inc. , Texas Health Care PLLC, and The GI Alliance company has posted strong financial growth in recent years, with revenue, EBITDA, and profit rising at a CAGR of 54.3%, 32.3%, and 26.1%, respectively, between FY22 and FY24. For the six months ended September 2024, revenue from operations doubled to Rs 1,283 crore, while net profit rose marginally to Rs 208 the lock-in period now over and the first wave of selling underway, market watchers are keenly observing whether more exits by early investors or promoters will follow in the coming weeks.